CLXT · Calyxt Inc

-

Please sign in to comment on CLXT

1 Comment

Admin

3 years, 7 months ago

Calyxt, Inc is currently in a long term downtrend where the price is trading 21.7% below its 200 day moving average.

From a valuation standpoint, the stock is 95.0% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 8.9.

Calyxt, Inc's total revenue rose by 270.1% to $14M since the same quarter in the previous year.

Its net income has dropped by 10.1% to $-13M since the same quarter in the previous year.

Finally, its free cash flow fell by 73.0% to $-13M since the same quarter in the previous year.

Based on the above factors, Calyxt, Inc gets an overall score of 2/5.

CurrencyCode	USD
Sector	Healthcare
ISIN	US13173L1070
Industry	Biotechnology
Exchange	NASDAQ

Target Price	0.73
Beta	2.11
PE Ratio	None
Dividend Yield	0.0%
Market Cap	15M

ABOUT

Calyxt Inc

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.

CLXT · Calyxt Inc

-

Calyxt Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Calyxt Inc using a moving average strategy